China
· Delayed Price · Currency is CNY Shanghai Medicilon Company Description
Shanghai Medicilon Inc., a drug discovery contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally.
It offers chemistry services, including medicinal, synthesis, and analytical chemistry services, as well as process development services; and drug formulation services, such as pre-formulation and analytical development services, as well as research on quality control and clinical trial material services.
The company also provides biology services comprising recombinant protein, crystallization and structural, discovery biology, computational biology and molecular modeling, and kinase services, as well as prepackaged M9 selenomethionine growth media kits and packages for growing cell culture in IPTG-inducible bacterial expression systems.
In addition, it offers pharmacology services, including cancer xenograft, metabolic disease, inflammation and immunological, neurological disorders, and other disease models; services in the areas of in vitro ADME and in vivo pharmacokinetics; and bioanalytical services, such as large and small molecule services.
Further, the company provides preclinical services comprising preclinical pharmacokinetic and safety evaluation.
Shanghai Medicilon Inc. was founded in 2004 and is headquartered in Shanghai, China.
| Country | China |
| Founded | 2004 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2,349 |
| CEO | Chunlin Chen |
Contact Details
Address: 585 Chuanda Road Shanghai, 201299 China | |
| Phone | 86 21 5859 1500 |
| Website | medicilon.com.cn |
Stock Details
| Ticker Symbol | 688202 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003NQ8 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Jianglin Hu | Joint Chief Executive Officer, Executive Vice President and Chief Strategy and Development Officer |
| Dr. Chun-Lin Chen Ph.D. | Co-Founder, Chairman and Chief Executive Officer |
| Shuangqing Peng Ph.D. | Chief Scientific Officer |
| Dr. Jinna Cai Ph.D. | Chief Commercial Officer, Deputy GM and Director |
| Binbin Liu | Deputy General Manager |
| Donghua Zhang | Financial Director |
| Dr. Lilly Xu Ph.D. | Chief Technology Officer |
| Jiang Xu MBA | Manager of Human Resources Department |
| Dr. Haizhou Zhang | President of Preclinical Research & Development Unit |
| Dr. Qingcong Lin | Deputy GM and Director |